• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

WHO Zika Virus, Microcephaly and Guillain-Barr? Syndrome Situation Report, October 13, 2016

Pathfinder

Editor, Senior Moderator
Zika situation report

13 October 2016

Zika virus, Microcephaly and Guillain-Barr? syndrome

Zika-timeline-september.png

Key updates
  • Countries and territories reporting mosquito-borne Zika virus infections for the first time in the past week:
    • None
  • Countries and territories reporting microcephaly and other central nervous system (CNS) malformations potentially associated with Zika virus infection for the first time in the past week:
    • None
  • Countries and territories reporting Guillain-Barr? syndrome (GBS) cases associated with Zika virus infection for the first time in the past week:
    • None

Analysis
  • Overall, the global risk assessment has not changed.
  • The risk of Zika-associated complications in countries thought to be endemic for Zika virus remains largely unknown, due both to uncertainty about the risk associated with different Zika strains, and due to uncertainty about population immunity in these endemic settings. To address the latter question, seroprevalence studies are urgently needed.
http://www.who.int/emergencies/zika-virus/situation-report/13-october-2016/en/
 
Back
Top